These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3792432)

  • 1. Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.
    Heykants J; Van Peer A; Woestenborghs R; Gould S; Mills J
    Eur J Clin Pharmacol; 1986; 31(3):343-50. PubMed ID: 3792432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ketanserin in patients with essential hypertension.
    Persson B; Pettersson A; Hedner T
    Eur J Clin Pharmacol; 1987; 32(3):259-65. PubMed ID: 3595699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol.
    Van Peer A; Woestenborghs R; Embrechts L; Heykants J
    Eur J Clin Pharmacol; 1986; 31(3):339-42. PubMed ID: 3792431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of ketanserin.
    Persson B; Heykants J; Hedner T
    Clin Pharmacokinet; 1991 Apr; 20(4):263-79. PubMed ID: 2036747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ketanserin in man.
    Reimann IW; Okonkwo PO; Klotz U
    Eur J Clin Pharmacol; 1983; 25(1):73-6. PubMed ID: 6617728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, metabolism and excretion of ketanserin in man after oral administration.
    Meuldermans W; Hendrickx J; Woestenborghs R; Van Peer A; Lauwers W; De Cree J; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):789-94. PubMed ID: 3178919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat.
    Heykants J; Michiels M; Woestenborghs R; Awouters F; Leysen JE; Schuurkes J; Van Nueten JM
    Arzneimittelforschung; 1988 Jun; 38(6):785-8. PubMed ID: 3178918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin pharmacokinetics in patients with renal failure.
    Barendregt JN; Van Peer A; Van Der Hoeven JG; Van Oene JC; Tjandra YI
    Br J Clin Pharmacol; 1990 Jun; 29(6):715-23. PubMed ID: 2378791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and pharmacokinetics of ketanserin in elderly subjects.
    Kurowski M
    Eur J Clin Pharmacol; 1985; 28(4):411-7. PubMed ID: 3161741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
    Jung D; Mroszczak E; Bynum L
    Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU; Vollmer KO
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ketanserin in patients with cirrhosis.
    Lebrec D; Hadengue A; Gaudin C; Levron JC; Fraitag B; Berthelot P; Benhamou JP
    Clin Pharmacokinet; 1990 Aug; 19(2):160-6. PubMed ID: 2379381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration.
    Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H
    Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.
    Williams FM; Leeser JE; Rawlins MD
    Br J Clin Pharmacol; 1986 Sep; 22(3):301-8. PubMed ID: 3768242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.
    Holazo AA; Colburn WA; Gustafson JH; Young RL; Parsonnet M
    J Pharm Sci; 1984 Aug; 73(8):1108-13. PubMed ID: 6491914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of ketanserin after a single dose and at steady-state in hypertensive subjects.
    Waller PC; Tucker GT; Ramsay LE
    Eur J Clin Pharmacol; 1987; 33(4):423-6. PubMed ID: 3443148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interactions of propranolol and ketanserin.
    Ochs HR; Greenblatt DJ; Höller M; Labedzky L
    Clin Pharmacol Ther; 1987 Jan; 41(1):55-60. PubMed ID: 3802706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.